Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1956 Jul;35(7):806–813. doi: 10.1172/JCI103333

RADIOTHYROXINE TURNOVER STUDIES IN MYXEDEMA, THYROTOXICOSIS, AND HYPERMETABOLISM WITHOUT ENDOCRINE DISEASE

Kenneth Sterling 1,2, Robert B Chodos 1,2
PMCID: PMC441650  PMID: 13332064

Full text

PDF
812

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBRIGHT E. C., LARSON F. C., TUST R. H. In vitro conversion of thyroxin to triiodothyronine by kidney slices. Proc Soc Exp Biol Med. 1954 May;86(1):137–140. doi: 10.3181/00379727-86-21031. [DOI] [PubMed] [Google Scholar]
  2. ASPER S. P., Jr, SELENKOW H. A., PLAMONDON C. A. A comparison of the metabolic activities of 3,5,3-L-triiodothyronine and L-thyroxine in myxedema. Bull Johns Hopkins Hosp. 1953 Sep;93(3):164–198. [PubMed] [Google Scholar]
  3. BARKER S. B., HUMPHREY M. J., SOLEY M. H. The clinical determination of protein-bound iodine. J Clin Invest. 1951 Jan;30(1):55–62. doi: 10.1172/JCI102416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BERSON S. A., YALOW R. S. Quantitative aspects of iodine metabolism: the exchangeable organic iodine pool, and the rates of thyroidal secretion, peripheral degradation and fecal excretion, of endogenously synthesized organically bound iodine. J Clin Invest. 1954 Nov;33(11):1533–1552. doi: 10.1172/JCI103032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BLACKBURN C. M., McCONAHEY W. M., KEATING F. R., Jr, ALBERT A. Calorigenic effects of single intravenous doses of L-triiodothyronine and L-thyroxine in myxedematous persons. J Clin Invest. 1954 Jun;33(6):819–824. doi: 10.1172/JCI102953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GROSS J., LEBLOND C. P. Metabolites of thyroxine. Proc Soc Exp Biol Med. 1951 Apr;76(4):686–689. doi: 10.3181/00379727-76-18595. [DOI] [PubMed] [Google Scholar]
  7. INGBAR S. H., FREINKEL N. Simultaneous estimation of rates of thyroxine degradation and thyroid hormone synthesis. J Clin Invest. 1955 Jun;34(6):808–819. doi: 10.1172/JCI103136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LARSON F. C., TOMITA K., ALBRIGHT E. C. The deiodination of thyroxine to triiodothyronine by kidney slices of rats with varying thyroid function. Endocrinology. 1955 Sep;57(3):338–344. doi: 10.1210/endo-57-3-338. [DOI] [PubMed] [Google Scholar]
  9. MAN E. B., KYDD D. M., PETERS J. P. Butanol-extractable iodine of serum. J Clin Invest. 1951 May;30(5):531–538. doi: 10.1172/JCI102469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. PITT-RIVERS R., STANBURY J. B., RAPP B. Conversion of thyroxine to 3-5-3'-triiodothyronine in vivo. J Clin Endocrinol Metab. 1955 May;15(5):616–620. doi: 10.1210/jcem-15-5-616. [DOI] [PubMed] [Google Scholar]
  11. STERLING K., LASHOF J. C., MAN E. B. Disappearance from serum of I131-labeled l-thyroxine and l-triiodothyronine in euthyroid subjects. J Clin Invest. 1954 Jul;33(7):1031–1035. doi: 10.1172/JCI102970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. STERLING K. The turnover rate of serum albumin in man as measured by I131-tagged albumin. J Clin Invest. 1951 Nov;30(11):1228–1237. doi: 10.1172/JCI102542. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES